Pantoprazole Reduces GI Damage in Critical Patients

Pantoprazole Reduces GI Damage in Critical Patients – MM1507

Pantoprazole is an irreversible proton pump inhibitor (PPI) that reduces gastric acid secretion. PPIs achieve a greater degree and longer duration of gastric acid suppression and better healing rates in various gastric acid-related disorders than histamine H2 receptor antagonists, making them essential in the management of gastrooesophageal reflux disease, peptic ulcer disease and Zollinger–Ellison syndrome.

Modern Medicine – July 2015